Login / Signup

SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors.

Tobias WalbertRebecca A HarrisonDavid SchiffEdward K AvilaMerry ChenPadmaja KandulaJong Woo LeeEmilie Le RhunGlen H J StevensMichael A VogelbaumWolfgang WickMichael WellerPatrick Y WenElizabeth R Gerstner
Published in: Neuro-oncology (2021)
In patients with newly diagnosed brain tumors who have not had a seizure, clinicians should not prescribe antiepileptic drugs (AEDs) to reduce the risk of seizures (level A). In brain tumor patients undergoing surgery, there is insufficient evidence to recommend prescribing AEDs to reduce the risk of seizures in the peri- or postoperative period (level C). There is insufficient evidence to support prescribing valproic acid or levetiracetam with the intent to prolong progression-free or overall survival (level C). Physicians may consider the use of levetiracetam over older AEDs to reduce side effects (level C). There is insufficient evidence to support using tumor location, histology, grade, molecular/imaging features when deciding whether or not to prescribe prophylactic AEDs (level U).
Keyphrases
  • newly diagnosed
  • primary care
  • patients undergoing
  • healthcare
  • minimally invasive
  • emergency department
  • percutaneous coronary intervention
  • quality improvement
  • temporal lobe epilepsy